Status:
COMPLETED
Effects of Peanut Consumption on Postprandial Inflammation, Glucose and Triglycerides
Lead Sponsor:
Penn State University
Collaborating Sponsors:
The Peanut Institute
Conditions:
Cardiovascular Disease
Eligibility:
MALE
30-50 years
Phase:
PHASE1
Brief Summary
This pilot study will investigate the effects of acute peanut consumption on markers of inflammation, triglycerides and glucose. The hypothesis is that a high glucose/SFA meal will increase postprandi...
Detailed Description
Previous research has demonstrated that a single meal high in saturated fatty acids (SFA) and glucose can induce increases in IL-6, TNF-α and CRP in abdominally obese and diabetic subjects. As over tw...
Eligibility Criteria
Inclusion
- BMI \>28
- LDL\_C below 130 mg/dl
- TG below 350 mg/dl
- Blood pressure within normal ranges (below 140/90 mmHg)
Exclusion
- Smoking
- Allergies to peanuts or dairy products
- Known intolerance for high fat meals
- History of CVD, kidney disease, diabetes or inflammatory disease
- Use of non-steroidal anti-inflammatories or immunosuppressants
- Conditions requiring the use of steroids
- Use of medication or supplements for elevated lipids, blood pressure or glucose
Key Trial Info
Start Date :
August 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2010
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT01173042
Start Date
August 1 2009
End Date
February 1 2010
Last Update
August 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Penn State University
University Park, Pennsylvania, United States, 16802